
Number of publications published per year by Wakabayashi, Kanji. (Source : PubMed)

Distribution of publications types for Wakabayashi, Kanji. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

On-treatment predictions of success in peg-interferon/ribavirin treatment using a novel formula.
World J. Gastroenterol.
2010;16;1

Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy.
Transl Res
2010;155;1
Visceral fat volume and the prevalence of colorectal adenoma.
Am. J. Epidemiol.
2009;170;12
Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice.
Int. J. Cancer
2009;125;11
Changes in blood coagulation-related parameters in phenobarbital-treated rabbits.
J Toxicol Sci
2009;34;4
Isolation and identification of a novel aromatic amine mutagen produced by the Maillard reaction.
Chem. Res. Toxicol.
2009;22;9
COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;14
Retinoic acid-inducible gene-I is constitutively expressed and involved in IFN-gamma-stimulated CXCL9-11 production in intestinal epithelial cells.
Immunol. Lett.
2009;123;1
Promotion of mouse two-stage skin carcinogenesis by diacylglycerol-rich edible oil.
Cancer Lett.
2009;275;1


Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
Clin. Exp. Immunol.
2009;155;3
[ See timeline ] [ See all publications ]
means that Wakabayashi, Kanji has 36 papers cited a least 36 times - methodology
Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Tokyo, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.